ZDHHC13 and melanoma: Importantly, our data show that concurrent activation of both downstream arms of ZDHHC13 signaling — enhanced CTNND1 palmitoylation and suppression of macrophage-derived MMP12 — produces the most robust inhibition of melanoma metastasis (Figure 9, A and B, and Supplemental Figure 19, A and B).